In Japan, the driver gene abnormalities in non-small cell carcinoma, which is the most common of the EGFR gene abnormalities, is reported as being due to a mutation found in 35% of patients with lung adenocarcinoma [30, 31]. Here, EGFR is linked to lung adenocarcinoma.